New Genetic Test Effectively Screens Newborns for Rare Disorders
A newly developed test to screen for three rare genetic disorders simultaneously in newborns was feasible, reliable, and scalable, recent research shows.
Read MorePosted by Andy Lundin | Jan 25, 2022 | Molecular Diagnostics |
A newly developed test to screen for three rare genetic disorders simultaneously in newborns was feasible, reliable, and scalable, recent research shows.
Read MorePosted by Andy Lundin | Jan 24, 2022 | Covid 19, POC Reagents & Test Kits |
A multiorganizational study is looking at how RNA reference materials can streamline efforts to make COVID-19 PCR test results more comparable between labs.
Read MorePosted by Andy Lundin | Jan 19, 2022 | Covid 19, Immunoassay Reagents & test Kits |
The study research suggests that rapid antigen tests can be confidently used to screen for adolescents who are infected but not showing symptoms.
Read MorePosted by Chris Wolski | Dec 30, 2021 | Covid 19, Immunoassay Reagents & test Kits, POC Rapid Assays |
Boston-based Northeastern University fully reopened in Fall 2021 thanks to a rigorous COVID testing program and an in-house laboratory.
Read MorePosted by Andy Lundin | Dec 28, 2021 | Cancer, Sequencing Systems |
NeoGenomics will use Thermo Fisher Scientific’s next-generation sequencing solution in a pharma-sponsored Phase 1 study of myeloid cancer.
Read More